Women’s Health • NEXSTELLIS® growth accelerating with Q3 FY23 field activity up dramatically over Q2 FY23, driven by access improvements and new targeting strategy • Transitioned the acquired branded women’s health portfolio into the Company’s promotion during the third quarter of FY23 and revenues increased over calendar Q4 2022 • Expect to launch lower strength BIJUVA® in fiscal year 2024
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.05 |
Change
0.040(0.80%) |
Mkt cap ! $410.2M | |||
| Open | High | Low | Value | Volume |
| $5.02 | $5.08 | $4.97 | $1.369M | 273.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1151 | $5.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.09 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |